Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling. Novo Nordisk's Ozempic will become the first and only GLP-1 drug to be shown to reduce progression of kidney ...
The Trump transition team is considering ways to shrink, consolidate or eliminate bank regulators in Washington, D.C., a move that would have a massive impact on agencies in charge of protecting ...